Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection
MASLD-HBV patients have worse liver fibrosis severity than MASLD patients, but better liver fibrosis stage than "HBV alone" patients, suggesting a complex interaction between MASLD and chronic HBV infection.
Authors
- Shaowen Wang (ORCID: https://orcid.org/0000-0001-5848-590X)
- Tsung‐Han Hsieh (ORCID: https://orcid.org/0000-0001-7096-2641)
- Chia‐Chi Wang (ORCID: https://orcid.org/0000-0002-1272-1513)
- Jia‐Horng Kao (ORCID: https://orcid.org/0000-0002-2442-7952)
- Yu‐Ming Cheng
- Yuwen Chang
- C. H. Wang
Institutions
- National Taiwan University (TW)
Publication Details
- Journal
- World Journal of Hepatology
- Published
- 2024-11-29
- DOI
- https://doi.org/10.4254/wjh.v16.i12.1429
- Citations
- 7
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71